This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
10 - 12 June, 2025
Congress CenterBasel Switzerland
BOOK NOW
Menu
BOOK NOW

David Overton
Senior Research Scientist II - Protein Science Pipeline at Immunocore
Speaker

Agenda Sessions

  • Development of a B-cell Targeted Immune Suppressive PD-1 Bispecific Agonist - A Novel Approach to Treat Type 1 Diabetes

    , 10:00
    View Session

At this event

Prev
Next
Niccolo Pengo, PhD
Chief Scientific Officer
Mabylon AG

See David at Antibody Engineering & Therapeutics Europe

BOOK NOW